ライフサイエンスコーパス: pregnant women

1 one in schoolchildren, one in adults, two in pregnant women).

2 cancers, and can be detected in the blood of pregnant women.

3 ve study involving 144 T. cruzi seropositive pregnant women.

4 acid versus iron-folic acid alone in 112 953 pregnant women.

5 een PFAS exposures and metabolic outcomes in pregnant women.

6 common neutrophil signature in males and in pregnant women.

7 show less symptoms of TMDs than that of non-pregnant women.

8 rticles, 85 countries, and a total of 299924 pregnant women.

9 ality, particularly among young children and pregnant women.

10 nformation including baseline iron stores in pregnant women.

11 ion of these, and is present in up to 18% of pregnant women.

12 net benefit of screening for preeclampsia in pregnant women.

13 (CO) over 72 hr among a cohort of Tanzanian pregnant women.

14 from food alone remains low in the diets of pregnant women.

15 eatments for active disease that are safe in pregnant women.

16 d 10 of 167 (6%; 95% CI, 3%-11%) symptomatic pregnant women.

17 ency virus (HIV)-uninfected and HIV-infected pregnant women.

18 most common strategy to manage drug abuse in pregnant women.

19 recommend universal iron supplementation for pregnant women.

20 globin <110g/L) as compared with non-anaemic pregnant women.

21 ction in high-risk populations, particularly pregnant women.

22 ng microcephaly, following ZIKV infection of pregnant women.

23 nce of group B streptococcus colonisation in pregnant women.

24 prostaglandin (PG) pathways are used by most pregnant women.

25 prevalent in many regions, especially among pregnant women.

26 harides (CPS) and pilus proteins in European pregnant women.

27 ea and vomiting affects approximately 85% of pregnant women.

28 of future malaria vaccination strategies in pregnant women.

29 Exposure: Zika virus infection in pregnant women.

30 of promising new tuberculosis drugs exclude pregnant women.

31 1, 2013, and Dec 31, 2015, we recruited 5781 pregnant women.

32 nce imaging is the best imaging modality for pregnant women.

33 r infants born to undernourished and anaemic pregnant women.

34 tions should also aim to reduce exposures to pregnant women.

35 obal health problem, affecting almost 50% of pregnant women.

36 icantly different between high- and low-risk pregnant women.

37 should focus on maximizing Tdap uptake among pregnant women.

38 ia is used in infants, children, adults, and pregnant women.

39 ing total 25(OH)D in a prospective cohort of pregnant women.

40 rch studies of iron status in North American pregnant women.

41 Of the 4 pregnant women, 1 gave birth to a healthy infant, 2 had

42 nd month after primary infection onset in 44 pregnant women (15 transmitting the infection to the fet

43 Among 1,151 enrolled pregnant women, 172 (15% [95% confidence interval [CI],

44 cy.Nested within a feeding study, 24 healthy pregnant women (26-29 wk of gestation) consumed a single

45 Thirteen of 44 pregnant women (30%) tested EVD positive; 6 of 13 (46%)

46 We studied forty-eight pregnant women (31 healthy volunteers and 17 with fetal

47 erse obstetrical events were recorded in 953 pregnant women (4.8%).

48 Participants were 24 pregnant women (48 eyes), monitored throughout pregnancy

49 in the vaginal microbiome in first trimester pregnant women, 52 with their first known conception, 26

50 macronutrients, and micronutrients for 1533 pregnant women.A third of the participants had total fat

51 e studies in which swabs were collected from pregnant women according to US Centers for Disease Contr

52 to characterize symptoms and outcomes among pregnant women admitted to Ebola treatment units (ETUs)

53 in the UK, at 16 fetal medicine centres, of pregnant women aged 16 years or older whose fetus had a

54 crocephaly, in the foetuses and offspring of pregnant women and (b) GBS in any population, and to des

55 The study excluded 182 pregnant women and 1650 adults in whom CVD risk data wer

56 oven association with fetal brain defects in pregnant women and acute neurological illness.

57 In intervention clusters, more pregnant women and children attained minimum dietary div

58 These are important results for pregnant women and clinicians to take into account in th

59 nt need to develop pretest education for all pregnant women and consistent post-test management recom

60 acterized maternal dietary patterns in Asian pregnant women and examined their associations with the

61 Studies assessing infectiousness of pregnant women and gametocyte dynamics during different

62 ncluding microcephaly in fetuses of infected pregnant women and Guillian-Barre syndrome in adults.

63 Although provision of SQ-LNSs to pregnant women and infants in Malawi may affect the age

64 a-attributable morbidity and mortality among pregnant women and infants who are too young to be vacci

65 study area and are of particular concern for pregnant women and infants.

66 rted for other general population samples of pregnant women and nonpregnant adults, was associated wi

67 A total of 26,184 pregnant women and their children were followed up at 2-

68 umulating datasets of genomic information on pregnant women and their fetuses raise ethical issues re

69 virus causes life-threatening infections in pregnant women and their newborns.

70 ravel advisories and prevention measures for pregnant women and their partners.

71 e associations between defense mechanisms in pregnant women and their toddlers' attachment security,

72 from randomisation to 34 weeks' gestation in pregnant women and to 24 weeks or conception in women pl

73 d routine supplementation among asymptomatic pregnant women and young children (6-24 mo old) in the U

74 iron supplementation of largely iron-replete pregnant women and young children (6-24 mo) in developed

75 creening and supplementation in iron-replete pregnant women and young children in 2016 in Bethesda, M

76 status, current estimates of iron status for pregnant women and young children in the United States a

77 harm of iron supplementation of iron-replete pregnant women and young children.

78 Twenty-five were controls (normotensive pregnant women) and 25 were pregnant women with preeclam

79 in children younger than 5 years and one in pregnant women), and nine IPT trials (five in children y

80 ldren; young to middle-age adults (including pregnant women); and elderly persons.

81 ed trivalent GBS vaccine in non-pregnant and pregnant women, and antibody transfer to their infants.

82 d >/=30 IU/L for men), incarcerated persons, pregnant women, and infants born to HBV-infected mothers

83 ects of CQ, its lack of contraindications in pregnant women, and its worldwide availability and low c

84 clinical trials typically have not included pregnant women, and when they are included, trials canno

85 ola, and Zika, are becoming more common, and pregnant women are at increased risk for associated comp

86 simetry deriving from (18)F-FDG injection in pregnant women are estimated from animal data.

87 Moreover, data on pregnant women are limited, and thus, data on women of r

88 Further longitudinal data in North American pregnant women are needed to help identify those who may

89 Pregnant women are particularly vulnerable to iron defic

90 Pregnant women are particularly vulnerable to iron defic

91 Because pregnant women are the main target population for ZIKV t

92 Women of reproductive age and particularly pregnant women are the most vulnerable to the adverse co

93 ent in mildly to moderately iodine-deficient pregnant women are urgently needed.

94 We randomly assigned 736 pregnant women at 24 weeks of gestation to receive 2.4 g

95 gnancy, and retinal microvascular changes in pregnant women at 26-28 weeks of pregnancy.

96 stage growth in vitro is reduced in anaemic pregnant women at baseline, but increased during supplem

97 rth drawn from a prospective birth cohort of pregnant women at Brigham and Women's Hospital in Boston

98 Pregnant women at Cairo University were screened for ant

99 In pregnant women at risk of having a child with asthma, su

100 hma Reduction Trial is a randomized trial of pregnant women at risk of having children with asthma ra

101 Therefore, the infants of pregnant women at risk of imminent preterm delivery may

102 (HBV) in all unvaccinated adults (including pregnant women) at risk for infection due to sexual, per

103 s were partly dependent on the proportion of pregnant women attending groups.

104 open-label, multicentre study, we recruited pregnant women attending two antenatal clinics, one in B

105 tor, hydroxychloroquine, approved for use in pregnant women, attenuated placental and fetal ZIKV infe

106 ra vaccination campaigns have often excluded pregnant women because of insufficient safety data for u

107 r effect on preterm births among underweight pregnant women (BMI <18.5 kg/m(2); RR 0.84, 95% CI 0.78-

108 Infection of pregnant women by Asian lineage strains of Zika virus (Z

109 Zika virus (ZIKV) infection of pregnant women can cause a wide range of congenital abno

110 ha, and IP-10 were observed in ZIKV-infected pregnant women carrying fetuses with fetal growth-associ

111 Both pregnant women carrying fetuses with heart defects and w

112 via Asia, it has become a serious threat to pregnant women, causing microcephaly and other neuropath

113 ational trivalent GBS vaccine in healthy non-pregnant women (cohort 1), and a dose-ranging study in h

114 hort 1), and a dose-ranging study in healthy pregnant women (cohort 2).

115 The pregnant women completed an interviewer-administered que

116 MEHP similar to those found in the urine of pregnant women consistently altered hCG and PPARgamma ex

117 Pregnant women cooking with kerosene or firewood were ra

118 Immunization of pregnant women could boost preexisting immune responses,

119 iciency virus (HIV) risk assessment tool for pregnant women could identify women who would most benef

120 From 1998 to 2013, 2270 HIV-infected pregnant women delivered 2692 newborns (270 born to PHIV

121 Pregnant women disproportionately underreport smoking an

122 to reduce malaria transmission often exclude pregnant women due to safety concerns related to the dru

123 al care providers to provide Tdap vaccine to pregnant women during routine prenatal visits at the ear

124 alciparum pathogenesis in vitro in RBCs from pregnant women during their 2nd and 3rd trimesters.

125 strate that serum samples from dengue-immune pregnant women enhanced ZIKV infection.

126 A total of 18,775 nulliparous pregnant women enrolled between 2006 and 2009 were rando

127 This prospective cohort study of 913 pregnant women examined the association between high MF

128 assessed maternal and perinatal outcomes in pregnant women exposed to anaesthesia for an obstetric p

129 ing point for scaling up, given its reach to pregnant women, families, and young children.

130 ed 30 articles including 20328 GBS-colonized pregnant women for inclusion.

131 Thalidomide was used by pregnant women for morning sickness but was removed from

132 of HIV risk and could be used to prioritize pregnant women for PrEP.

133 findings support the importance of screening pregnant women for Zika virus exposure.

134 with household air pollution in a cohort of pregnant women from Dar es Salaam, Tanzania.

135 In 2009-2010, 80 pregnant women from Ottawa Canada participated in the Pl

136 Among 587 pregnant women from the EDEN (Etude des Determinants pre

137 two consecutive sequential annual cohorts of pregnant women from the Sarlahi district in southern Nep

138 We analyzed 1,240 pregnant women from the Spanish INMA [Environment and Ch

139 al pathology with household air pollution in pregnant women from urban/periurban Tanzania who cook pr

140 The risk of EOGBS among GBS-colonized pregnant women, from this first systematic review, is co

141 Only five (5%) of 107 pregnant women had an uneventful outcome.

142 e supplementation in mildly iodine-deficient pregnant women had no effect on child neurodevelopment a

143 rtality (0.71, 0.60-0.86; p=0.04) in anaemic pregnant women (haemoglobin <110g/L) as compared with no

144 KEY POINTS: Older pregnant women have a greater risk of operative delivery

145 intakes in various populations suggest that pregnant women have difficulty meeting all their nutriti

146 immunodeficiency virus research field, where pregnant women have enjoyed better-although imperfect-re

147 ion and one of two on offering disadvantaged pregnant women help to quit smoking that reported on our

148 Among pregnant women ibuprofen is one of the most frequently u

149 Participants were pregnant women identified and recruited in the study clu

150 during gestational weeks 38.8+/-1.1 from 398 pregnant women in a prospective birth cohort enrolled in

151 human immunodeficiency virus (HIV)-infected pregnant women in Africa.

152 (DP) to daily TMP-SMX alone in HIV-infected pregnant women in an area of Uganda where indoor residua

153 lined substantially in the 21st century, but pregnant women in areas of sustained transmission still

154 n this randomised, placebo-controlled trial, pregnant women in Bangalore, India, and Bangkok, Thailan

155 dies, support use of oral cholera vaccine in pregnant women in cholera-affected regions.

156 ed micronutrient supplementation trial among pregnant women in Dar es Salaam, Tanzania (2001-2004).

157 ng which dengue is diagnosed and to consider pregnant women in dengue control policies.

158 cific serodiagnostic tests, particularly for pregnant women in dengue virus (DENV)-endemic regions.

159 Understanding the iron status in pregnant women in Europe provides a foundation for consi

160 pen-label trial of treatments for malaria in pregnant women in four African countries.

161 in 2014 from vaginal/rectal swabs of healthy pregnant women in metropolitan Toronto, Canada.

162 ve on the risk/benefit tradeoff of including pregnant women in research to address different forms of

163 Anaemia and malaria are both common in pregnant women in Sub-Saharan Africa.

164 a community perspective on the inclusion of pregnant women in TB drug research and discuss (1) our p

165 magnetic resonance imaging (MRI) findings in pregnant women in the Department of Diagnostic Imaging,

166 PHIV vs nonperinatally HIV-infected (NPHIV) pregnant women in the Pediatric HIV/AIDS Cohort Study Su

167 Among HIV-infected pregnant women in the setting of indoor residual sprayin

168 cent years, short-term antiviral therapy for pregnant women in the third trimester has been shown to

169 Among pregnant women in the United States with completed pregn

170 A cohort of pregnant women in their early third trimester (n = 81) w

171 Among pregnant women in Washington State, low and high prepreg

172 with circulating vitamin D metabolites among pregnant women [including a CYP27B1-associated increase

173 tachment intervention targeting impoverished pregnant women increased more than 2.5-fold when only sh

174 Cytomegalovirus (CMV) urinary shedding in pregnant women infected with human immunodeficiency viru

175 desh, we randomized geographical clusters of pregnant women into individual water treatment, sanitati

176 hain reaction screening of T. cruzi-infected pregnant women is a useful tool for predicting the risk

177 vidence regarding its impact on HIV-infected pregnant women is lacking.

178 on approaches may reduce DDT/DDE exposure in pregnant women living in IRS communities.

179 , 2016, in which timing of ART initiation in pregnant women living with HIV was reported.

180 d appropriate treatment of hypothyroidism in pregnant women may be an area for possible prevention of

181 A total of 30 pregnant women (mean gestational age, 26 weeks) with a s

182 measured plasma PFAS concentrations in 1,645 pregnant women (median, 9.6 weeks gestation) enrolled in

183 However, pregnant women might represent an important source of hu

184 d on levels found previously in the urine of pregnant women: mono-n-butyl (MnBP, 200 nM), monobenzyl

185 A prospective cohort study in Chinese pregnant women (n = 3220) was conducted to investigate t

186 WR) in a multiethnic Asian cohort.We studied pregnant women (n = 653) recruited between June 2009 and

187 Another cohort of first-time pregnant women (n=1 093 342) from the medical birth regi

188 3 half-life were measured in third-trimester pregnant women (n22) and repeated during lactation 12 we

189 In this cohort of HIV-infected pregnant women not on antiretrovirals, urinary CMV shedd

190 In Malawi, pregnant women of any gravidity status were tested at ea

191 Maintaining addicted pregnant women on long-acting opioid receptor agonist is

192 e supplementation in mildly iodine-deficient pregnant women on neurodevelopment of their offspring in

193 B compared with term birth in two cohorts of pregnant women: one predominantly Caucasian (n = 39) at

194 am in the program area among households with pregnant women or caregivers in rural villages with low

195 rhPAPPA and PAPPA in the serum samples from pregnant women or conditioned medium of trophoblast cell

196 ematologic indexes in otherwise asymptomatic pregnant women or in infants within populations who are

197 Care of pregnant women or new mothers with botulism can include

198 Pregnant women or patients who needed urgent medical att

199 o recommend routine iron supplementation for pregnant women or routine screening for iron deficiency

200 tine screening for iron deficiency anemia in pregnant women or young children.

201 egies (targeting vaccination for infants, or pregnant women, or prophylactic antibodies for neonates)

202 uman immunodeficiency virus (HIV)-uninfected pregnant women protected by indoor residual spraying of

203 Influenza immunization of pregnant women protects their young infants against labo

204 A total of 5076 (8.8%) pregnant women received trivalent influenza vaccine and

205 It has been reported that pregnant women receiving protease inhibitor (PI)-based c

206 ng anthropometry for moderately malnourished pregnant women receiving ready-to-use supplemental food

207 HIV-infected pregnant women receiving rilpivirine 25 mg once daily we

208 preeclamptic (n=49) and normotensive (n=42) pregnant women recruited at delivery.

209 3001 infants were born to pregnant women recruited between Oct 1, 2013, and Feb 10

210 Since 2007, all pregnant women referred to give birth at Hvidovre Hospit

211 rformed a prospective observational study of pregnant women referred to our maternal-fetal medicine d

212 inical need for TB prevention and treatment, pregnant women remain neglected by research initiatives.

213 ity; however, influenza vaccination rates of pregnant women remain under 50%.

214 ngle-center, nonblinded study among selected pregnant women require confirmation in multicenter clini

215 Importantly, infection of the blood of pregnant women revealed an enhanced susceptibility to ZI

216 pecifically, Asian-lineage ZIKV infection of pregnant women's blood led to an exacerbated M2-skewed i

217 rotein A (PAPPA) is specifically elevated in pregnant women serum, and is known to promote trophoblas

218 ear unless drug clearance is documented, and pregnant women should be educated on the risks of anti-T

219 Pregnant women show less symptoms of TMDs than that of n

220 d these can be especially dangerous, because pregnant women suffer higher virus-associated morbidity

221 cohort with essentially complete follow-up, pregnant women taking supplemental folic acid at or abov

222 included articles with >/=200 GBS colonized pregnant women that reported IAP coverage.

223 in New York State for symptomatic patients, pregnant women, their infants, and patients with Guillai

224 with the classic anthropomorphic phantoms of pregnant women, then into OLINDA/EXM 2.0 to assess the d

225 randomized 720 geographical clusters of 5551 pregnant women to a control or an intervention arm.

226 To do nothing would allow thousands of pregnant women to expose their fetuses to an infection t

227 , and Feb 11, 2014, we randomly assigned 569 pregnant women to placebo and 565 to cholecalciferol 100

228 20) and high- (n = 9) and low-risk (n = 16) pregnant women to probes of varying sizes and surface ch

229 th these multigenerational effects may allow pregnant women to safely reap the benefits of nanotechno

230 pment, with those targeting older adults and pregnant women (to protect young infants) in phase 2 and

231 s abortion, death, and congenital defects in pregnant women treated with any of the following: 1) a v

232 MATERIAL/Forty-three symptomatic pregnant women underwent MRI between 9 and 33 weeks of g

233 We found a small difference in HbA1c in pregnant women using CGM (mean difference -0.19%; 95% CI

234 The mean (SD) age of the 3033 pregnant women was 32.4 (4.7) years, and their mean (SD)

235 e "barrier" to maternal glucocorticoids), by pregnant women was associated with pubertal maturation (

236 A prospective cohort of 635 Beninese pregnant women was recruited before 24 weeks of gestatio

237 Of these, 60 non-pregnant women were enrolled in cohort 1 (40 randomly as

238 domly assigned to the placebo group) and 320 pregnant women were enrolled in cohort 2 (80 in each of

239 A total of 239 pregnant women were enrolled; 32 blood samples (13.4%) w

240 Pregnant women were excluded.

241 Pregnant women were less likely than nonpregnant women t

242 In cohort 1, non-pregnant women were randomly assigned (2:1) to receive t

243 al Asthma Reduction Trial (VDAART), in which pregnant women were randomly assigned to vitamin D suppl

244 Pregnant women were recruited between 2003 and 2008.

245 s (PASTURE) is a European birth cohort where pregnant women were recruited between August 2002 and Ma

246 s double-blind randomized clinical trial, 90 pregnant women were recruited in the Prey Veng province,

247 131 ZIKV-PCR positive pregnant women were scored for clinical disease severity

248 togenes causes foodborne systemic disease in pregnant women, which can lead to preterm labor, stillbi

249 interventions, including drug treatment, in pregnant women who are obese or overweight have not had

250 EOGBS) occurs in neonates (days 0-6) born to pregnant women who are rectovaginally colonized with gro

251 revent or significantly attenuate viremia in pregnant women who are residents of or travelers to epid

252 ernative treatment option for HIV-1-infected pregnant women who are virologically suppressed, in sett

253 ce volunteers undertook home visits for 7848 pregnant women who gave birth to 7786 live babies in 200

254 These patients included 6 pregnant women who later delivered during the course of

255 We report fetal outcomes for 1 of 4 pregnant women who participated in an observational stud

256 mpaign in Tororo, Uganda, among HIV-infected pregnant women who received bed nets, daily trimethoprim

257 d a prospective cohort study in Zambia among pregnant women who received intermittent preventive trea

258 Moreover, we included 2 pregnant women who underwent fetal MRI and had incidenta

259 The study enrolled pregnant women who visited the outpatient clinic for ant

260 Including pregnant women will increase intervention coverage and i

261 were drawn from a cohort whose partners were pregnant women with a due date between April 25, 2009, a

262 stigated the prevalence of bacteriuria among pregnant women with and without UTI symptoms in Uganda.

263 ral infections that showed that treatment of pregnant women with antiviral drugs or hyperimmunoglobul

264 STF recommends screening for preeclampsia in pregnant women with blood pressure measurements througho

265 monitoring decisions and risk assessment for pregnant women with CHD at the time of delivery.

266 While pregnant women with confirmed EVD had similar Ebola vira

267 associated with an improved birth outcome in pregnant women with documented PAM.

268 the risk of venous thromboembolism (VTE) in pregnant women with essential thrombocythemia.

269 immunodeficiency virus (HIV) in HIV-infected pregnant women with high CD4 counts are lacking.

270 reduce malaria and preterm birth risk among pregnant women with HIV receiving bed nets, daily trimet

271 in combination with autotaxin, distinguished pregnant women with itch that would subsequently develop

272 Translationally, pregnant women with low or high ACEs were examined for t

273 Limited data were available in infants and pregnant women with malaria as well as in healthy indivi

274 Pregnant women with malnutrition and malaria infection a

275 sk of adverse maternal and fetal outcomes in pregnant women with mechanical heart valves who received

276 was conducted in southern Malawi among 1828 pregnant women with moderate malnutrition, defined as a

277 evels in the amniotic fluid of ZIKV-positive pregnant women with neonatal microcephaly.

278 Thyroid antibodies in pregnant women with normal functioning thyroids (ie, eut

279 c pathways in murine models and samples from pregnant women with normally grown and large-for-gestati

280 Pregnant women with polycystic ovary syndrome (PCOS) are

281 ls (normotensive pregnant women) and 25 were pregnant women with preeclampsia, including those with g

282 rtain if HCMV DNA in the peripheral blood of pregnant women with primary HCMV infection at the time o

283 CMV-specific T cells by cultured ELISPOT, in pregnant women with primary HCMV infection, in associati

284 In pregnant women with primary infection, the cultured ELIS

285 ansmitting the infection to the fetus) and 8 pregnant women with remote infection.

286 Subsequently, eligibility was expanded to pregnant women with sexual partners with similar travel

287 A total of 1136 pregnant women with singleton pregnancies were recruited

288 Pregnant women with suspected EVD had the same risk, how

289 rt a difference in the risk of death between pregnant women with suspected or confirmed EVD compared

290 antenatal care and immunisation coverage of pregnant women with tetanus toxoid.

291 Vaccination of pregnant women with trivalent inactivated influenza vacc

292 Pregnant women with type 1 diabetes are a high-risk popu

293 CGM should be offered to all pregnant women with type 1 diabetes using intensive insu

294 The prevalence of culture-proven UTI among pregnant women with UTI symptoms was 4%.

295 Infection of pregnant women with Zika virus (ZIKV) can cause congenit

296 No therapeutic options are available to pregnant women with ZIKV infection to prevent these effe

297 Among 56 IPT-DP recipients (26 children, 30 pregnant women) with cardiac parameters, all QTc interva

298 Hospitalised children and adults (including pregnant women) with severe influenza A or B (defined as

299 GBS colonizes pregnant women worldwide, but prevalence and serotype di

300 and serotype distribution of GBS colonizing pregnant women worldwide.